CDK9 inhibitors modulate the transcriptional landscape of colorectal cancer to suppress MAPK signaling and synergizes with BRAF inhibitors to treat BRAF-mutant colorectal cancer

被引：0
|
作者：
Kuang, Chaoyuan
Wei, Ning
Mohammadi, Mahshid
Bhat, Muzaffer A.
Li, Terence
Patil, Priyanka
Wiltz, Othon
Huang, Renee
Ooka, Kohtaro
Quintal, Melanie
Chu, Edward
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-1218
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1218
引用
收藏
页数：2
相关论文
共 50 条
  • [1] THE MAPK PATHWAY IS A THERAPEUTIC TARGET IN BRAF-MUTANT COLORECTAL CANCER
    不详
    CANCER DISCOVERY, 2015, 5 (11) : 1122 - 1122
  • [2] Hitting the Target in BRAF-Mutant Colorectal Cancer
    Nagaraja, Ankur K.
    Bass, Adam J.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (34) : 3990 - +
  • [3] Management of BRAF-mutant metastatic colorectal cancer
    Burge, Matthew
    Whitehall, Vicki
    COLORECTAL CANCER, 2016, 5 (04) : 131 - 133
  • [4] Targeted therapy for BRAF-mutant colorectal cancer
    Gunjur, Ashray
    LANCET ONCOLOGY, 2019, 20 (11): : E618 - E618
  • [5] Molecular targeted therapy of BRAF-mutant colorectal cancer
    Ducreux, Michel
    Chamseddine, Ali
    Laurent-Puig, Pierre
    Smolenschi, Cristina
    Hollebecque, Antoine
    Dartigues, Peggy
    Samallin, Emmanuelle
    Boige, Valerie
    Malka, David
    Gelli, Maximiliano
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2019, 11
  • [6] BRAF-mutant colorectal cancer, a different breed evolving
    Lai, Eleonora
    Pretta, Andrea
    Impera, Valentino
    Mariani, Stefano
    Giampieri, Riccardo
    Casula, Laura
    Pusceddu, Valeria
    Coni, Pierpaolo
    Fanni, Daniela
    Puzzoni, Marco
    Demurtas, Laura
    Ziranu, Pina
    Faa, Gavino
    Scartozzi, Mario
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2018, 18 (06) : 499 - 512
  • [7] Kinase Inhibitor in a Patient with BRAF-mutant Colorectal Cancer
    Sakumura, Miho
    Ando, Takayuki
    Ueda-Consolvo, Tomoko
    Motoo, Iori
    Mihara, Hiroshi
    Kajiura, Shinya
    Teramoto, Akira
    Nanjo, Sohachi
    Fujinami, Haruka
    Yasuda, Ichiro
    INTERNAL MEDICINE, 2022, 61 (11) : 1707 - 1712
  • [8] Treatment options in BRAF-mutant metastatic colorectal cancer
    Bernabe-Ramirez, Carolina
    Patel, Rajvi
    Chahal, Jaspreet
    Saif, Muhammad Wasif
    ANTI-CANCER DRUGS, 2020, 31 (06) : 545 - 557
  • [9] B-Raf Inhibitors Induce Epithelial Differentiation in BRAF-Mutant Colorectal Cancer Cells
    Herr, Ricarda
    Koehler, Martin
    Andrlova, Hana
    Weinberg, Florian
    Moeller, Yvonne
    Halbach, Sebastian
    Lutz, Lisa
    Mastroianni, Justin
    Klose, Martin
    Bittermann, Nicola
    Kowar, Silke
    Zeiser, Robert
    Olayioye, Monilola A.
    Lassmann, Silke
    Busch, Hauke
    Boerries, Melanie
    Brummer, Tilman
    CANCER RESEARCH, 2015, 75 (01) : 216 - 229
  • [10] Antitumor Activity of BRAF Inhibitor Vemurafenib in Preclinical Models of BRAF-Mutant Colorectal Cancer
    Yang, Hong
    Higgins, Brian
    Kolinsky, Kenneth
    Packman, Kathryn
    Bradley, William D.
    Lee, Richard J.
    Schostack, Kathleen
    Simcox, Mary Ellen
    Kopetz, Scott
    Heimbrook, David
    Lestini, Brian
    Bollag, Gideon
    Su, Fei
    CANCER RESEARCH, 2012, 72 (03) : 779 - 789
12345